Warfarin

The medicine warfarin, which MeSH calls an anticoagulant.

  • Drug
  • In 2 atlases

Overview

Technical summary

RxNorm concept 11289 is the ingredient warfarin (term type IN). The federal Substance Registration System lists UNII 5Q7ZVV76EI as the chemical substance WARFARIN. MeSH descriptor D014859 is Warfarin, and its indexing note calls it an anticoagulant and rodenticide. This identity is the substance only. It covers no dose, product, salt form or use, and the uses of warfarin belong to the interventions and recommendations that cite it.

Trials at a glance

The figures count the 33 registry trials in this atlas that name this drug or a product that contains it. Trials that use another name for it are not counted.

Trials
33
Phase 3 or 4
27
Recruiting
4
Regulatory decisions
0
Trials by phase (rows) and registry status (columns)
PhaseRecruitingNot yet recruitingActive, not recruitingCompletedTerminatedUnknown statusAll statuses
Phase 20003025
Phase 2/30001001
Phase 321051110
Phase 4202110217
All phases412201533

Conditions these trials study

And 9 more.

Sponsors with the most trials

The lead sponsor of each trial, as the registry names it.

And 25 more.

About this drug

Level
Substance
Mechanism
Not reported

Claims and evidence

No claims are published for this drug yet.

Registry records

Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.

Registry trials 31

Record details

Record id
core:warfarin
Content hash
e2069e6c21bd0b8db6720c6603c4c1b7d724d9edbec831ea4c36b70feb97df87